Literature DB >> 19515370

Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy.

Monique A Ford1, Joseph P McConnell, Shahar Lavi, Charanjit S Rihal, Abhiram Prasad, Gurpreet S Sandhu, Stacy J Hartman, Lilach O Lerman, Amir Lerman.   

Abstract

OBJECTIVE: The association between cholesterol and endothelial dysfunction remains controversial. We tested the hypothesis that lipoprotein subclasses are associated with coronary endothelial dysfunction. METHODS AND
RESULTS: Coronary endothelial function was assessed in 490 patients between November 1993 and February 2007. Fasting lipids and nuclear magnetic resonance (NMR) lipoprotein particle subclasses were measured. There were 325 females and 165 males with a mean age of 49.8+/-11.6 years. Coronary endothelial dysfunction (epicardial constriction>20% or increase in coronary blood flow<50% in response to intracoronary acetylcholine) was diagnosed in 273 patients, the majority of whom (64.5%) had microvascular dysfunction. Total cholesterol and LDL-C (low density lipoprotein cholesterol) were not associated with endothelial dysfunction. One-way analysis and multivariate methods adjusting for age, gender, diabetes, hypertension and lipid-lowering agent use were used to determine the correlation between lipoprotein subclasses and coronary endothelial dysfunction. Epicardial endothelial dysfunction was significantly correlated with total (p=0.03) and small LDLp (LDL particles) (p<0.01) and inversely correlated with total and large HDLp (high density lipoprotein particles) (p<0.01).
CONCLUSIONS: Epicardial, but not microvascular, coronary endothelial dysfunction was associated directly with LDL particles and inversely with HDL particles, suggesting location-dependent impact of lipoprotein particles on the coronary circulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515370      PMCID: PMC2783869          DOI: 10.1016/j.atherosclerosis.2009.04.039

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

Review 1.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 3.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

4.  Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

Authors:  A Chait; R L Brazg; D L Tribble; R M Krauss
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

5.  Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes.

Authors:  R J Woodman; G F Watts; D A Playford; J D Best; D C Chan
Journal:  Diabetes Obes Metab       Date:  2005-09       Impact factor: 6.577

Review 6.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

7.  Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.

Authors:  Robert S Rosenson; James D Otvos; David S Freedman
Journal:  Am J Cardiol       Date:  2002-07-15       Impact factor: 2.778

8.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

9.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

Authors:  J Johansson; L A Carlson; C Landou; A Hamsten
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

10.  Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.

Authors:  Lewis Kuller; Alice Arnold; Russell Tracy; James Otvos; Greg Burke; Bruce Psaty; David Siscovick; David S Freedman; Richard Kronmal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-07-01       Impact factor: 8.311

View more
  13 in total

1.  Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis.

Authors:  R J Widmer; M A Freund; A J Flammer; J Sexton; R Lennon; A Romani; N Mulinacci; F F Vinceri; L O Lerman; A Lerman
Journal:  Eur J Nutr       Date:  2012-08-08       Impact factor: 5.614

2.  Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans.

Authors:  Patrice Armstrong; Darshan S Kelley; John W Newman; Frank E Staggers; Janna Hartiala; Hooman Allayee; Charles B Stephensen
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

3.  Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents.

Authors:  Russell Jago; Kimberly L Drews; James D Otvos; Gary D Foster; Marsha D Marcus; John B Buse; Michele Mietus-Snyder; Steven M Willi
Journal:  J Pediatr       Date:  2014-02-05       Impact factor: 4.406

4.  Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice.

Authors:  Nada Sallam; Anat Fisher; Saeid Golbidi; Ismail Laher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-04       Impact factor: 3.000

5.  Lipoprotein particle concentrations in children and adults following Kawasaki disease.

Authors:  Jonathan Lin; Sonia Jain; Xiaoying Sun; Victoria Liu; Yuichiro Z Sato; Susan Jimenez-Fernandez; Ron S Newfield; Ray Pourfarzib; Adriana H Tremoulet; John B Gordon; Lori B Daniels; Jane C Burns
Journal:  J Pediatr       Date:  2014-07-16       Impact factor: 4.406

6.  Microbial translocation and metabolic and body composition measures in treated and untreated HIV infection.

Authors:  Tamara Timmons; Changyu Shen; Grace Aldrovandi; Adrienne Rollie; Samir K Gupta; James H Stein; Michael P Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-08       Impact factor: 2.205

7.  Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study.

Authors:  Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; Tracey E Toms; Douglas Carroll; George D Kitas
Journal:  BMC Musculoskelet Disord       Date:  2012-07-23       Impact factor: 2.362

8.  Histamine blood concentration in ischemic heart disease patients.

Authors:  Vladimir Zdravkovic; Suzana Pantovic; Gvozden Rosic; Aleksandra Tomic-Lucic; Nemanja Zdravkovic; Maja Colic; Zdravko Obradovic; Mirko Rosic
Journal:  J Biomed Biotechnol       Date:  2011-06-06

Review 9.  Endothelial dysfunction and cardiovascular disease.

Authors:  R Jay Widmer; Amir Lerman
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

10.  Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus.

Authors:  Robert S Rosenson; Scott P Rigby; Michael R Jones; Hubert S Chou
Journal:  Cardiovasc Drugs Ther       Date:  2014-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.